Amgen, Inc. - Strategy and SWOT Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.
Detailed information on Amgen, Inc. required for business and competitor intelligence needs
A study of the major internal and external factors affecting Amgen, Inc. in the form of a SWOT analysis
An in-depth view of the business model of Amgen, Inc. including a breakdown and examination of key business segments
Intelligence on Amgen, Inc.’s mergers and acquisitions (M&A), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
News about Amgen, Inc., such as business expansion, restructuring, and contract wins
Large number of easy-to-grasp charts and graphs that present important data and key trends
Amgen (or 'the company') is a biotechnology company engaged in the discovery, development, manufacture, and marketing of innovative human therapeutics. The company mainly focuses in the areas of cancer, kidney disease, rheumatoid arthritis and other serious illnesses. It primarily operates in the US where it is headquartered in Thousand Oaks, California. Amgen employed about 17,900 people as on December 31, 2014. The company recorded revenues of $20,063 million during the financial year ended December 2014 (FY2014), an increase of 7.4% over FY2013. The operating profit of the company was $6,191 million in FY2014, an increase of 5.5% over FY2013. The net profit of the company was $5,158 million in FY2014, an increase of 1.5% over FY2013.
Reasons to Purchase:
Gain understanding of Amgen, Inc. and the factors that influence its strategies
Track strategic initiatives of the company and latest corporate news and actions
Assess Amgen, Inc. as a prospective partner, vendor or supplier
Support sales activities by understanding your customers' businesses better
Stay up to date on Amgen, Inc.’s business structure, strategy and prospects